Days after exiting bankruptcy, radiology provider Envision appoints interim CEO

Fresh off of exiting the bankruptcy process, radiology provider Envision Healthcare announced it is appointing an interim chief executive officer.

Henry Howe will take over the role on Dec. 1, with current CEO Jim Rechtin transitioning out of the organization by the end of the November. The former OptumCare executive first took over Envision’s top post in February 2020 and announced in October that he is leaving to fill the same position at health insurance giant Humana in 2024.

“We thank Jim for his leadership through the worst of the COVID-19 pandemic and the recent restructuring,” Howe, who has served as Envision’s chief financial officer since March 2021, said in a Nov. 7 announcement. “I am honored to lead Envision during this transition,” he added later. “Our priority remains ensuring clinicians are empowered in the delivery of care, patients continue receiving high-quality care when they need it most and our hospital partners experience the same level of service they have come to expect.”

Howe previously served as Envision’s interim CFO beginning in December 2020 after joining the organization as executive VP of enterprise strategy in April of the same year. He has held various leadership positions and also previously led strategic initiatives at Bridgewater Associates.

Nashville, Tennessee-based Envision also announced on Tuesday that it is appointing Steve Nelson as chairman of its board of directors. He currently serves as president of ChenMed, a primary care provider for seniors.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup